F. Eric Preston
#156,823
Most Influential Person Now
F. Eric Preston's AcademicInfluence.com Rankings
F. Eric Prestonbiology Degrees
Biology
#12134
World Rank
#15589
Historical Rank
Evolutionary Biology
#291
World Rank
#314
Historical Rank
Genetics
#1322
World Rank
#1424
Historical Rank
Molecular Biology
#1937
World Rank
#1968
Historical Rank
Download Badge
Biology
F. Eric Preston's Degrees
- PhD Genetics University of California, Berkeley
- Masters Biology Stanford University
Similar Degrees You Can Earn
Why Is F. Eric Preston Influential?
(Suggest an Edit or Addition)F. Eric Preston's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Geographic Distribution of the 20210 G to A Prothrombin Variant (1998) (716)
- Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C (1997) (536)
- Fish consumption and mortality from coronary heart disease. (1985) (370)
- Factor VIII gene inversions in severe hemophilia A: results of an international consortium study. (1995) (343)
- The postoperative fibrinolytic shutdown: a rapidly reverting acute phase pattern for the fast-acting inhibitor of tissue-type plasminogen activator after trauma. (1985) (324)
- Inhibition of prostacyclin and platelet thromboxane A2 after low-dose aspirin. (1981) (294)
- Investigation and management of heritable thrombophilia (2001) (291)
- Identity of viridans streptococci isolated from cases of infective endocarditis. (1993) (281)
- ACUTE ENCEPHALOPATHY COINCIDENT WITH SEROCONVERSION FOR ANTI-HTLV-III (1985) (262)
- The effects of dietary omega-3 polyunsaturated fatty acids on erythrocyte membrane phospholipids, erythrocyte deformability and blood viscosity in healthy volunteers. (1985) (246)
- Hepatitis C antibody and chronic liver disease in haemophilia (1990) (245)
- Inhibition of activated protein C and its cofactor protein S by antiphospholipid antibodies (1990) (234)
- Demonstration of viraemia patterns in haemophiliacs treated with hepatitis-C-virus-contaminated factor VIII concentrates (1990) (216)
- HLA Class II Profile: A Weak Determinant of Factor VIII Inhibitor Development in Severe Haemophilia A (1997) (207)
- A comparison of the efficacy and rate of response to oral and intravenous Vitamin K in reversal of over‐anticoagulation with warfarin (2001) (206)
- Co-inheritance of the 20210A Allele of the Prothrombin Gene Increases the Risk of Thrombosis in Subjects with Familial Thrombophilia (1997) (198)
- ELEVATED β-THROMBOGLOBULIN LEVELS AND CIRCULATING PLATELET AGGREGATES IN DIABETIC MICROANGIOPATHY (1978) (198)
- High prevalence of a mutation in the factor V gene within the U.K. population: relationship to activated protein C resistance and familial thrombosis (1994) (179)
- EFFECT OF DICHLOROMETHYLENE DIPHOSPHONATE IN PAGET'S DISEASE OF BONE AND IN HYPERCALCÆMIA DUE TO PRIMARY HYPERPARATHYROIDISM OR MALIGNANT DISEASE (1980) (178)
- The natural history of chronic hepatitis C in haemophiliacs (1996) (173)
- Beneficial effect of fish oil on blood viscosity in peripheral vascular disease. (1984) (157)
- Prostacyclin increases cyclic AMP levels and adenylate cyclase activity in platelets (1977) (144)
- Genetic analysis, phenotypic diagnosis, and risk of venous thrombosis in families with inherited deficiencies of protein S. (2000) (142)
- Essential Thrombocythaemia and Peripheral Gangrene (1974) (136)
- HYPOTHYROIDISM AS A CAUSE OF ACQUIRED VON WDLLEBRAND'S DISEASE (1987) (131)
- PLATELET ABNORMALITIES IN DIABETIC PERIPHERAL NEUROPATHY (1975) (120)
- PROGRESSIVE LIVER DISEASE IN HAEMOPHILIA: AN UNDERSTATED PROBLEM? (1985) (120)
- Recurrence Rate After a First Venous Thrombosis in Patients With Familial Thrombophilia (2005) (104)
- Precise Carrier Diagnosis in Families with Haemophilia A: Use of Conformation Sensitive Gel Electrophoresis for Mutation Screening and Polymorphism Analysis (1998) (103)
- The relationship between inhibition of vitamin K1 2,3-epoxide reductase and reduction of clotting factor activity with warfarin. (1988) (103)
- Antithrombins Wibble and Wobble (T85M/K): archetypal conformational diseases with in vivo latent-transition, thrombosis, and heparin activation. (1998) (95)
- Fibrinolysis during normal human pregnancy: complex inter‐relationships between plasma levels of tissue plasminogen activator and inhibitors and the euglobulin clot lysis time (1988) (94)
- A randomized controlled trial of recombinant interferon-alpha in chronic hepatitis C in hemophiliacs. (1991) (90)
- Heterogeneity of hepatitis C virus genotypes in hemophilia: relationship with chronic liver disease. (1995) (90)
- Guidelines on oral anticoagulation: second edition (1990) (88)
- Effects of dietary fish oil supplementation on the fatty acid composition of the human platelet membrane: demonstration of selectivity in the incorporation of eicosapentaenoic acid into membrane phospholipid pools. (1985) (84)
- The Therapeutic Range for Heparin Therapy: Relationship between Six Activated Partial Thromboplastin Time Reagents and Two Heparin Assays (1996) (83)
- Cerebral intravascular coagulation in diabetic ketoacidosis. (1974) (81)
- The use of dichloromethylene diphosphonate for the management of hypercalcaemia in multiple myeloma (1983) (80)
- Hepatitis C viral RNA in clotting factor concentrates and the development of hepatitis in recipients. (1993) (80)
- Mode of action of dipyridamole on human platelets. (1979) (79)
- Stanozolol-Induced Changes in Fibrinolysis and Coagulation in Healthy Adults (1984) (77)
- A comparative evaluation of assays for markers of activated coagulation and/or fibrinolysis: thrombin–antithrombin complex, D‐dimer and fibrinogen/fibrin fragment E antigen (1990) (77)
- Disseminated intravascular coagulation as a consequence of cerebral damage (1974) (76)
- PERCUTANEOUS LIVER BIOPSY AND CHRONIC LIVER DISEASE IN HÆMOPHILIACS (1978) (71)
- Relationship between platelet aggregation, thromboxane synthesis and albumin concentration in nephrotic syndrome (1982) (68)
- Familial thrombophilia: genetic risk factors and management (1997) (65)
- Protein C and protein S in homozygous sickle cell disease: does hepatic dysfunction contribute to low levels? (1997) (63)
- Factor VIII gene rearrangements in patients with severe haemophilia A (1994) (61)
- Cellular hyperviscosity as a cause of neurological symptoms in leukaemia. (1978) (60)
- A reassessment of vascular factors in relation to intravascular coagulation. (1976) (59)
- Protein C, antithrombin III and plasminogen: effect of age, sex and blood group (1994) (59)
- Thrombocytosis, circulating platelet aggregates, and neurological dysfunction. (1979) (59)
- Acquired von Willebrand's disease: demonstration of a circulating inhibitor to the factor VIII complex in four cases (1983) (57)
- Low risk of viral infection after administration of vapor‐heated factor VIII concentrate (1992) (56)
- The role of immunoglobulin G and fibrinogen in platelet aggregation by Streptococcus sanguis (1997) (54)
- Recommendations for the treatment of factor VIII inhibitors: from the UK Haemophilia Centre Directors' Organisation Inhibitor Working Party. (1996) (54)
- Modulation of Rapid Plasminogen Activator Inhibitor in Plasma by Stanozolol (1984) (53)
- The Fibrinolytic Response To Stanozolol In Normal Subjects (1981) (52)
- Detection by PCR of hepatitis C virus in factor VIII concentrates (1990) (50)
- A rapid method for haemophilia B mutation detection using conformation sensitive gel electrophoresis (1999) (49)
- Mechanisms of platelet aggregation by Streptococcus sanguis, a causative organism in infective endocarditis (1993) (49)
- Evidence against Vitamin K Deficiency in Normal Neonates (1980) (49)
- Effects of epoxymethano analogues of prostaglandin endoperoxides on aggregation, on release of 5-hydroxytryptamine and on the metabolism of 3',5'-cyclic AMP and cyclic GMP in human platelets. (1979) (47)
- Plasma 6-keto-prostaglandin F1α: Fact or fiction (1982) (47)
- Characterization of Serum Fibrinogen and Fibrin Fragments Produced during Disseminated Intravascular Coagulation (1978) (47)
- Hyposplenism in inflammatory bowel disease. (1978) (47)
- Evidence against a platelet cyclooxygenase defect in uraemic subjects on chronic haemodialysis (1986) (46)
- Low-dose aspirin inhibits platelet and venous cyclo-oxygenase in man. (1982) (46)
- Myelomatosis and the Hyperviscosity Syndrome (1978) (45)
- Induction of immune tolerance in patients with hemophilia A and inhibitors treated with porcine VIIIC by home therapy. (1990) (45)
- A placebo-controlled, double-blind study of eicosapentaenoic acid-rich fish oil in patients with stable angina pectoris. (1990) (44)
- Gangrene of the Toes with Palpable Peripheral Pulses. Response to Platelet Suppressive Therapy (1981) (43)
- NON-A, NON-B HEPATITIS AND HEAT-TREATED FACTOR VIII CONCENTRATES (1985) (43)
- Abnormal vitamin K metabolism in the presence of normal clotting factor activity in factory workers exposed to 4-hydroxycoumarins. (1986) (43)
- Guide-lines for near patient testing: haematology. (1995) (42)
- Rapid two-stage PCR for detecting factor V G1691A mutation (1994) (42)
- Thrombovascular disease and familial plasminogen deficiency: a report of three kindreds (1988) (41)
- Assessment of Actin FS and Actin FSL sensitivity to specific clotting factor deficiencies. (1998) (41)
- Investigation of the relative infectivity and pathogenicity of different hepatitis C virus genotypes in hemophiliacs. (1996) (38)
- A Comparison of Methods for the Measurement of Activated Factor VII (1992) (38)
- Further evidence that activated protein C resistance can be misdiagnosed as inherited functional protein S deficiency (1994) (37)
- Platelet aggregation by oral streptococci. (1990) (37)
- Reduced risk of non‐A, non‐B hepatitis after a first exposure to ‘wet heated’factor VIII concentrate (1987) (37)
- The incidence of factor VIII inhibitors in the United Kingdom, 1990‐93 (1995) (37)
- Evidence for the involvement of complement proteins in platelet aggregation by Streptococcus sanguis NCTC 7863 (1996) (37)
- Treatment of the hypercalcaemia of malignancy with intravenous clodronate. (1987) (37)
- Reduced coagulation activation following infusion of a highly purified factor IX concentrate compared to a prothrombin complex concentrate (1993) (37)
- Characterisation of Type 2N von Willebrand Disease Using Phenotypic and Molecular Techniques (1996) (36)
- Molecular basis of protein S deficiency in three families also showing independent inheritance of factor V leiden. (1996) (35)
- Antithrombin Sheffield: amino acid substitution at the reactive site (Arg393 to His) causing thrombosis (1989) (34)
- In vivo coagulation activation following infusion of highly purified factor XI concentrate (1997) (34)
- Aspirin, prostaglandins, and peripheral gangrene. (1983) (33)
- The routine measurement of platelet volume: a comparison of aperture-impedance and flow cytometric systems. (1985) (33)
- Protein C, an anticoagulant protein, is increased in healthy volunteers and surgical patients after treatment with stanozolol. (1984) (32)
- Major Structural Defects in the Antithrombin Gene in Four Families with Type I Antithrombin Deficiency (2000) (32)
- FAMILIAL PLASMINOGEN DEFICIENCY AND THROMBOEMBOLISM (1988) (31)
- Factor VIII inhibitor by-passing activity (FEIBA) in the management of patients with factor VIII inhibitors. (1977) (31)
- WET HEATING FOR SAFER FACTOR VIII CONCENTRATE? (1985) (30)
- DIPYRIDAMOLE AND PLATELET FUNCTION (1978) (29)
- Relationships between Haemostatic Factors and Capillary Morphology in Human Diabetic Neuropathy (1992) (29)
- Approach to the bleeding patient (2001) (28)
- Platelet aggregation in patients with peripheral vascular disease. (1978) (28)
- The management of von Willebrand's disease-associated gastrointestinal angiodysplasia (2001) (28)
- Clinical and histological studies in diabetic neuropathy (1976) (26)
- A cross‐over pharmacokinetic and thrombogenicity study of a prothrombin complex concentrate and a purified factor IX concentrate (1994) (26)
- Hyposplenism in ulcerative colitis. (1974) (26)
- Predictive markers of chronic liver disease in hemophilia. (1987) (25)
- CHRONIC LIVER DISEASE IN HAEMOPHILIACS (1990) (24)
- Chronic hepatitis in haemophilia. (1993) (24)
- Guidelines on the prevention, investigation and management of thrombosis associated with pregnancy. Maternal and Neonatal haemostasis Working Party of the Haemostasis and Thrombosis Task. (1993) (24)
- Association between necropsy evidence of disseminated intravascular coagulation and coagulation variables before death in patients in intensive care units. (1988) (24)
- Near-normal glycaemic control does not correct abnormal platelet reactivity in diabetes mellitus. (1984) (24)
- PLATELET AND VASCULAR ARACHIDONIC ACID METABOLITES: CAN THEY HELP DETECT A TENDENCY TOWARDS THROMBOSIS? * (1984) (24)
- Cerebral involvement with disseminated intravascular coagulation in intestinal disease. (1977) (23)
- Warfarin Induced Skin Necrosis Associated with Activated Protein C Resistance (1996) (23)
- 10 Protein C and protein S (1989) (23)
- Activated protein C resistance in homozygous sickle cell disease (1997) (23)
- Antithrombin Cambridge II (Ala384Ser): Clinical, Functional and Haplotype Analysis of 18 Families (1998) (22)
- Letter: Diabetic ketoacidosis presenting as neurosurgical emergencies. (1974) (21)
- Recurrent multiple-branch retinal arteriolar occlusions in a patient with protein C deficiency (2005) (21)
- A Novel Mutation in Intron K of the PROS1 Gene Causes Aberrant RNA Splicing and Is a Common Cause of Protein S Deficiency in a UK Thrombophilia Cohort (1998) (21)
- Guidelines on the diagnosis, management and prevention of hepatitis in haemophilia. (2001) (21)
- The hypercoagulable state in clinical practice. (1991) (20)
- Influence of the −675 4G/5G dimorphism of the plasminogen activator inhibitor 1 promoter on thrombotic risk in patients with factor V Leiden (2000) (20)
- The successful use of protein C concentrate during pregnancy in a patient with type 1 protein C deficiency, previous thrombosis and recurrent fetal loss (1997) (20)
- Neurological complications in clinical haematology (1980) (19)
- Relationship between splenic size and splenic function. (1978) (18)
- EFFECT OF GLUCOSE ON PLATELET THROMBOXANE BIOSYNTHESIS (1979) (17)
- Lifelong penicillin unproved in trials.. (1994) (17)
- Demonstration of abnormal factor VIII multimers in acquired von Willebrand's disease associated with a circulating inhibitor (1987) (17)
- Coagulation disturbances following ascites recirculation. (1990) (17)
- Do Extra-Platelet Sources Contribute to the Plasma Level of Thrombospondin? (1988) (16)
- Guidelines on the diagnosis and management of chronic liver disease in haemophilia (1995) (16)
- Reduced tissue type plasminogen activator activity of the gastroduodenal mucosa in peptic ulcer disease. (1993) (16)
- Advanced laboratory methods in haematology (2002) (16)
- Platelet aggregation by oral streptococci (1990) (16)
- Intestinal disaccharidase activity in psoriatic enteropathy. (1971) (15)
- A new familial‘giant platelet syndrome’ with structural, metabolic and functional abnormalities of platelets due to a primary megakaryocyte defect (1987) (15)
- Elevated von Willebrand factor antigen predicts deterioration in diabetic peripheral nerve function (1996) (15)
- An Evaluation and Improvement Program for Inpatient Anticoagulant Control (1997) (15)
- Changes in the factor VIII complex in diabetic ketoacidosis: evidence of endothelial cell damage? (1987) (15)
- CUMULATIVE INHIBITORY EFFECT OF DAILY 40 mg ASPIRIN ON PROSTACYCLIN SYNTHESIS (1981) (15)
- CORTICAL AND VASCULAR PROSTAGLANDIN SYNTHESIS DURING RENAL ALLOGRAFT REJECTION IN THE RAT (1987) (15)
- Microvascular thrombosis of the bowel in paroxysmal nocturnal haemoglobinuria. (1987) (15)
- A rapid and cost effective method for analysis of dinucleotide repeat polymorphisms in the factor VIII gene (1996) (15)
- Acquired Glanzmann's thrombasthenia [letter] (1983) (14)
- A comparison of the allelic frequencies of ten DNA polymorphisms associated with factor VIII and factor IX genes in Thai and Western European populations (1994) (14)
- Potential value of vintristine‐adriamycin‐dexamethasone combination chemotherapy (VAD) in refractory and rapidly progressive myeloma (1987) (14)
- Acquired dysfibrinogenaemia masquerading as disseminated intravascular coagulation in acute pancreatitis. (1988) (14)
- The effect of beta-adrenoceptor antagonists on the pharmacokinetics and pharmacodynamics of warfarin after a single dose. (1984) (14)
- The platelet defect in acute myeloid leukaemia. (1984) (14)
- Changes in Haematological Indices, Blood Viscosity and Inhibitors of Coagulation during Treatment of Endometriosis with Danazol (1994) (13)
- Increased soluble IL‐2 receptor levels in HCV‐infected haemophiliacs: a possible indicator of liver disease severity (1994) (13)
- A Common Splice Site Mutation Is Shared by Two Families with Different Type 2N von Willebrand Disease Mutations (1999) (13)
- A study of the stimulation of human venous prostacyclin synthesis by dipyridamole. (1982) (13)
- Audit of oral anticoagulant treatment. The BCSH Haemostasis and Thrombosis Task Force of the British Society for Haematology. (1993) (12)
- THROMBOXANE AND PROSTACYCLIN SYNTHESIS IN EXPERIMENTAL PANCREAS TRANSPLANTATION1: CHANGES IN PARENCHYMAL AND VASCULAR PROSTANOIDS (1993) (12)
- Potential thrombogenicity of heat‐treated prothrombin complex concentrates in Haemophilia B (1991) (12)
- Effect of Stanozolol on Factors VIII and IX and Serum Aminotransferases in Haemophilia (1985) (11)
- Resistance to activated protein C. (1994) (11)
- Familial antithrombin III deficiency and Mycoplasma pneumoniae pneumonia. (1991) (11)
- EFFECT OF STANOZOLOL ON ANTITHROMBIN III AND PROTEIN C (1983) (11)
- Intravascular coagulation and E. coli septicaemia (1973) (11)
- Wobble ( T 85 M / K ) : Archetypal Conformational Diseases With In Vivo Latent-Transition , Thrombosis , and Heparin Activation (1998) (11)
- Euglobulin clot lysis time (1992) (10)
- Clinical Annotation. THE HYPERCOAGULABLE STATE IN CLINICAL PRACTICE (1991) (10)
- Mesenteric infarction due to combined protein C deficiency and prothrombin 20210 defects (1999) (10)
- Interferon alfa for chronic hepatitis C in haemophiliacs. (1993) (10)
- A haemorrhagic platelet disorder associated with altered stimulus‐response coupling and abnormal membrane phospholipid composition (1994) (10)
- Acquired Glanzmann's thrombasthenia. (1983) (10)
- ABC of clinical haematology: Bleeding disorders, thrombosis, and anticoagulation (1997) (10)
- A method for the determination of activated factor VII using bovine and rabbit brain thromboplastins: demonstration of increased levels in disseminated intravascular coagulation. (1988) (10)
- Computed tomography: qualitative and quantitative recognition of liver disease in haemophilia. (1983) (9)
- Rapid assessment of haemophilia A carrier state by non-invasive techniques using the polymerase chain reaction. (1990) (9)
- Prevention of hepatitis C virus infection in haemophiliacs (1990) (9)
- DN 9693: A Phosphodiesterase Inhibitor with a Platelet Membrane Effect (1989) (9)
- Postpartum purpura fulminans: successful management with streptokinase. (1973) (9)
- Microangiopathic haemolytic anaemia: The phenomenon of red cell adherence (1970) (9)
- 227 Familial plasminogen deficiency and thrombovascular disease (1988) (9)
- Acute renal failure in myelomatosis from intravascular coagulation. (1972) (9)
- Need for second-generation anti-HCV testing in haemophilia (1992) (8)
- Antiphospholipid Antibody Syndrome (1988) (8)
- Lack of effect of a 24-hour infusion of iloprost in intermittent claudication. (1987) (8)
- Thrombotic vascular disease. (1985) (7)
- Heparinised Clotting Factor Concentrates in Patients with Christmas Disease and Liver Disease (1977) (7)
- Bleeding time in patients with hepatic cirrhosis. (1990) (7)
- Changes in plasma osteocalcin concentration following treatment with stanozolol. (1986) (7)
- PLATELET SUPPRESSIVE THERAPY IN CLINICAL MEDICINE (1985) (7)
- Acute hereditary tyrosinaemia type I: Clinical, biochemical and haematological studies in twins (1981) (7)
- The Effect of Stanozolol on the Fibrinolytic Enzyme System in Normal Subjects (1981) (7)
- Rebuttal to: Oral Contraceptives and Venous Thromboembolism (2001) (6)
- PROTHROMBIN-COMPLEX CONCENTRATES IN LIVER DISEASE (1975) (6)
- Severe disseminated intravascular coagulation associated with massive ventricular mural thrombus following acute myocardial infarction. (1988) (6)
- Hemolytic-uremic syndrome: demonstration of abnormalities of platelet reactivity and insensitivity to prostaglandin I2. (1985) (6)
- Circulatory Complications of Leukaemia and Paraproteinaemia (1981) (6)
- Orbital plasmacytoma in established myeloma--a report of two cases. (1986) (6)
- LIVER DISEASE IN HAEMOPHILIA (1985) (5)
- Natural history of skeletal disease in multiple myelomatosis and treatment with clodronate (1992) (5)
- CLINICAL AND LABORATORY FEATURES ASSOCIATED WITH LUPUS ANTICOAGULANT (1987) (5)
- Prostacyclin and thromboxane A (1982) (5)
- Intravascular coagulation and pre-eclamptic toxaemia. (1972) (5)
- The effect of beta-adrenoceptor antagonists on the pharmacokinetics and pharmacodynamics of warfarin. (1984) (5)
- Antibody-mediated tissue damage. Hyperviscosity and other complications of paraproteinaemia. (1979) (5)
- Disseminated intravascular coagulation with thymoma-associated Cushing's syndrome. (1973) (5)
- Evaluation of a global screening assay for the investigation of the protein C anticoagulant pathway. (2000) (5)
- The Effects of Diet and Insulin Therapy on Coagulation Factor VII, Blood Viscosity, and Platelet Release Proteins in Diabetic Patients with Secondary Sulphonylurea Failure (1991) (5)
- Serial Changes in the Coagulation System Following Clotting Factor Concentrate Infusion (1975) (4)
- A biopsy-controlled trial of interferon alfa-2b in chronic NANB hepatitis in hemophiliacs (1990) (4)
- Surface ultramicroscopy of neonatal erythrocytes. (1970) (4)
- URINARY THROMBOXANE AND 6‐KETO-PROSTAGLANDIN F1α ARE EARLY MARKERS OF ACUTE REJECTION IN EXPERIMENTAL PANCREAS TRANSPLANTATION1 (1994) (4)
- Studies on the incorporation of eicosapentaenoic acid (EPA) into platelet membrane phospholipids and the effects of EPA supplementation on platelet function, skin bleeding time and blood viscosity in man. (1984) (4)
- Tentative protocol for the evaluation of coagulometers, based on one-stage prothrombin time. (1981) (4)
- TYPE III PRO-COLLAGEN PEPTIDE IN LIVER DISEASE IN HAEMOPHILIA (1987) (3)
- Protein C and protein S. (1989) (3)
- Proceedings: Abnormalities of splenic function in ulcerative colitis and Crohn's disease. (1975) (3)
- HYPOTHYROIDISM AND ACQUIRED VON WILLEBRAND'S DISEASE (1987) (3)
- The Kidney and Intravascular Coagulation in Myelomatosis (1974) (3)
- Plasma 6-keto-prostaglandin F1alpha: fact or fiction. (1982) (3)
- BLOOD PRODUCT CONCENTRATES AND CHRONIC LIVER DISEASE (1982) (3)
- Newer techniques in the study of hemostatic disorders. (1978) (3)
- Platelet function and coagulation in patients with hepatobiliary disorders receiving cefotetan prophylaxis (1988) (3)
- PLATELET MEMBRANE GLYCOPROTEIN ABNORMALITIES IN MYELOPROLIFERATIVE DISEASE (1986) (3)
- DNA polymorphisms for carrier detection of hemophilia in Thailand. (1995) (2)
- A simple technique for studying immunoglobulin synthesis by normal and malignant plasma cells in vitro. (1977) (2)
- Non-surgical management of peripheral vascular disease. (1981) (2)
- Electron microscope findings in the jejunal mucosa of patients with psoriasis (2004) (2)
- Interferon-alpha treatment and formation of factor VIII antibodies. (1997) (2)
- Fibrinolysis in myelomatosis. (1972) (2)
- GUIDELINES ON THE DIAGNOSIS AND MANAGEMENT OF CHRONIC LIVER-DISEASE IN HEMOPHILIA (1995) (2)
- Intravascular coagulation and renal failure in E. coli septicaemia. (1972) (2)
- Interferon- Treatment and Formation of Factor VIII Antibodies (1997) (2)
- COMPARISON OF HUMAN AND RABBIT BRAIN THROMBOPLASTIN IN EVALUATION OF HAEMOSTATIC DEFECT OF LIVER DISEASE (1986) (2)
- IMPROVED DIABETIC CONTROL AND PLATELET REACTIVITY (1985) (2)
- The Factor VIII Molecule in Acquired Von Willebrand’s Disease (1977) (1)
- PARADOXICAL INCREASE IN HUMAN FACTOR VIII AFTER INFUSION OF PORCINE FACTOR VIII CONCENTRATE IN A PATIENT WITH ACQUIRED VARIANT VON WILLEBRAND'S DISEASE (1987) (1)
- TYPE I PLASMINOGEN DEFICIENCY AND THROMBOVASCULAR DISEASE IN THREE KINDREDS (1988) (1)
- A role for vitronectin in platelet aggregation by Streptococcus sanguis (1996) (1)
- Dipyridamole Reverses The Inhibitory Effect Of Aspirin On Prostacyclin Synthesis (1981) (1)
- Effects of Dipyridamole and Aspirin on Platelet camp Levels and Prostaglandin Biosynthesis in vivo in Patients with Diabetes Mellitus (1979) (1)
- Abnormal platelet reactivity in diabetic microvascular disease: Is thromboxane synthesis related to platelet arachidonic acid content? (1987) (1)
- Skin Disease and the Gut (1970) (1)
- An immunoradiometric assay for porcine factor VIII related antigen. (1980) (1)
- The Diagnosis and Clinical Management of Thrombophilia (1993) (1)
- Mucosal Plasminogen Activator Activity in Peptic Ulcer Disease (1992) (1)
- Haemorrhage and factor IX deficiency in pituitary insufficiency. (1983) (1)
- Cerebral involvement withdisseminated intravascular coagulation inintestinal disease (1977) (1)
- Responsiveness of adenylate cyclase in human blood platelets (1977) (1)
- Vascular endothelium in haemostasis and thrombosis. Michael A. Gimbrone Jr. (Ed.) Churchill Livingstone, 1986. No. of pages 250. ISBN 0443 030642 (1989) (1)
- von Willebrand Factor/Factor VIII Binding Is not Affected by the Arg89Gln Polymorphism in von Willebrand Factor (1996) (1)
- FIBRINOLYSIS AND HAEMOSTASIS DURING ASCITES RECIRCULATION (1987) (1)
- Proceedings: Intravascular coagulation in the nervous system. (1975) (1)
- The Association of Clinical Pathologists: 80th general meeting (1968) (1)
- Factor VII Clotting Assays: Influence of Thromboplastin (1993) (1)
- Liver biopsy in haemophilia. (1997) (1)
- Potential Clinical use of Diphosphonates Against Bone Metastases and Hypercalcaemia of Malignancy (1980) (0)
- Massive bladder haemorrhage (1986) (0)
- A modified 14C-Serotonin platelet release method for the diagnosis of Heparin-Induced Thrombocytopenia (HIT) (1995) (0)
- 77 The relationship between plasma d-dimer and serum fragment E levels in hypercoagulable states (1988) (0)
- The use of high gradient magnetic separation for the preparation of leucocyte- and platelet-free red cell suspensions (2016) (0)
- Mode of Action of Dipyridamole on Human Platelets. Potentiation of Prostacyclin Effects (1978) (0)
- PROTECTIVE EFFECT OF VITAMIN K AGAINST ACETAMINOPHEN (PARACETAMOL) TOXICITY IN THE HAMSTER (1987) (0)
- septicaemia . renal failure in E . coli Intravascular coagulation and (2004) (0)
- Fibrin in the kidney in myelomatosis. (1972) (0)
- inhibitors treated with porcine VIIIC by home therapy Induction of immune tolerance in patients with hemophilia A and (2011) (0)
- Panel discussion on the treatment of inhibitors: Today and tomorrow (1995) (0)
- The Factor VIII Response To High Purity Porcine Factor VIII Concentrate In Acquired Von Willebrand’s Disease (1981) (0)
- Abstracts of Papers Presented at the Annual General Meeting of the British Society for Haematology held in London, 24 and 25 March 1977 (1977) (0)
- Disseminated intravascular coagulation. New approaches to diagnosis and treatment (1986) (0)
- Platelets, red cells and vascular disease (1988) (0)
- Platelet Function Studies in Diabetics with Peripheral Neuropathy (1979) (0)
- care units . death in patients in intensive coagulation variables before intravascular coagulation and evidence of disseminated Association between necropsy (2005) (0)
- Year book of haematology 1987: Edited by J. L. Spivak. Wolfe Medical Publications Ltd, London, 1987. pp 372. £38.00 (1987) (0)
- DIPYRIDAMOLE AND PLATELET FUNCTION (1978) (0)
- P6. Diphosphonates in multiple myelomatosis (1989) (0)
- P68. Moderate severity haemophilia A complicated by inhibitors (1996) (0)
- Platelet activation by Streptococcus sanguis is mediated by specific antibody and alternative complement pathway activation via the Fc receptor (1995) (0)
- 2014 – STUDIES ON THE MECHANISMS OF ACTION OF DIPYRIDAMOLE ON HUMAN PLATELETS AND ITS INTERACTION WITH PROSTACYCLIN (PGI2) (1978) (0)
- INTERFERON-ALPHA TREATMENT AND FORMATION OF FACTOR VIII ANTIBODIES. AUTHORS' REPLY (1997) (0)
- Precise carrier and prenatal diagnosis in families with haemophilia A facilitated by conformational sensitive gel electrophoresis for mutation screening and polymorphism analysis (1997) (0)
- DETERMINATION OF ACTIVATED FACTOR VII BY BOVINE AND RABBIT THROMBOPLASTINS. (1987) (0)
- TheKidneyandIntravascular Coagulation inMyelomatosis (1974) (0)
- Biosynthesis of Factor VIII Related Antigen (VIII. RAG) by Porcine Aortic Endothelial Cells in Culture (1983) (0)
- The Use Of A Cell-Free Synthesis System For The Study Of Factor FVIII (1981) (0)
- Answer to the Letter of Dr. R. Jimenez “The Use of Prophylactic Vitamin K at Birth” (1981) (0)
- 408 Reduced fibrinolytic activity in lipodermatosclerosis (LDS) (1988) (0)
- Characterization of type 2N von Willebrand disease using molecular and phenotypic analysis (1995) (0)
- Evidence for a Functional ADP Receptor in Platelets in Glanzmann's Thrombasthenia (1978) (0)
- ORAL ANTICOAGULANTS AND FETAL LOSS. AUTHORS' REPLY (1996) (0)
- Disseminated intravascular coagulation. (1982) (0)
- Massive cardiac disease in a patient with Waldenstrom's macroglobulinaemia. (1988) (0)
- Diphosphonates Are Effective in Controlling Hypercalcaemia in Malignant Disease (1982) (0)
- Panel discussion on the development of inhibitors: Who and why? (1995) (0)
- Inhibition And Recovery Of Prostacycun And Thromboxane A After Low-Dose Aspirin (1981) (0)
- HAEMOSTATIC PARAMETERS, ENDONEURIAL OXYGEN TENSION AND SURAL NERVE HISTOLOGY IN DIABETES MELLITUS (1987) (0)
- Frozen increments (1976) (0)
- A useful photometric test for the diagnosis of Von Willebrand's disease (2018) (0)
- COMPARISON OF HUMAN AND RABBIT BRAIN THROMBOPLASTIN IN THE EVALUATION OF LIVER DISEASE (1987) (0)
- Does HIV infection accelerate malignant transformation of pre‐malignant states? (1992) (0)
- Proceedings: Essential thrombocythaemia and peripheral vascular disease. (1974) (0)
- The Effect of Vitamin K on Pivka and its Associated Procoagulant Proteins in Liver Disease (1977) (0)
- Essentials of haemostasis and thrombosis: L. A. Kay. Churchill Livingstone, Edinburgh, 1988. pp 296. £12.50 (1989) (0)
- Enhanced Biosynthesis of Malonyldialdehyde by Diabetic Platelets (1978) (0)
- Therelationship between inhibition ofvitamin K12,3-epoxide reductase andreduction ofclotting factor activity withwarfarin (1988) (0)
- Experience of liver disease in haemophilia (1982) (0)
- P9 The molecular basis of antithrombin deficiency: a survey of twelve kindred (1996) (0)
- Enhancement of protein C by stanozolol in healthy adults and in surgical patients : abstract (1983) (0)
- GENESRCH: a computer program for restriction fragment analysis. (1991) (0)
- ESSENTIAL THROMBOCYTHAEMIA (1982) (0)
- Disseminated intravascular coagulation asa consequenceofcerebral damage (1974) (0)
- Measurement Of Platelet Nucleotides By Reverse-Phase HPLC, And The Demonstration Of Acquired Storage Pool Defect In D.I.C (1981) (0)
- LIVER DISEASE IN HÆMOPHILIACS (1978) (0)
- Multiple Myeloma and Paraprotein Disorders (1987) (0)
- Haemostasis & Thrombosis I (1996) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With F. Eric Preston?
F. Eric Preston is affiliated with the following schools:
